Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 12, Issue 3, 2005, Pages 165-169

  Babu, R Jayachandra ^a   Pandit, Jayanta Kumar ^b  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bupranolol; Flux; Penetration Enhancers; Transdermal

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 2 PROPANOL; 2 PYRROLIDINONE; BUPRANOLOL; MENTHOL; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MIXTURE; DRUG PENETRATION; DRUG SOLUBILITY; FEMALE; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SKIN; SKIN PENETRATION;

2-PROPANOL; ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BUPRANOLOL; CELL MEMBRANE PERMEABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; MALE; MENTHOL; PROPYLENE GLYCOL; PYRROLIDINONES; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; TIME FACTORS; WATER;

EID: 18044397839     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540590931936     Document Type: Article

References (28)

1. Babu, R. J., and Pandit, J. K. 2004. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin. Int. J. Pharm. 271:155-165.
2. Barry, B. W. 1987. Mode of action of penetration enhancers in human skin. J. Control. Rel. 6:85-97.
3. Barry, B. W., and Williams, A. C. 1995. Permeation enhancement through skin. In Encyclopedia of Pharmaceutical Technology, ed. J. Swarbrick and J. C. Boylon, 449-465. New York: Marcel Dekker.
4. Cordes, G., Fischer, W., Legler, U., and Wolff, H. M. 1988. Development of a novel transdermal therapeutic system for bupranolol. Ther. Res. 8:139-153.
5. Godwin, D. A., Michniak, B. B., Player, M. P., and Sowell Sr, J. W. 1997. Transdermal and dermal enhancing activity of pyrrolidones in hairless mouse skin. Int. J. Pharm. 155:241-250.
6. Goodman, M., and Barry, B. W. 1988. Action of penetration enhancers on human skin as assessed by the permeation of model drugs, 5-fluorouracil and oestradiol. I. Infinite dose technique. J. Invest. Dermatol. 91:323-327.
7. Green, P. G., Hadgraft, J., and Wolff, M. 1989. Physicochemical aspects of the transdermal delivery of bupranolol. Int. J. Pharm. 55:265-269.
8. Hori, M., Satoh, S., Maibach, H. I., and Guy, R. H. 1991. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci. 80:32-35.
9. Kararli, T., Kirchhoff, C. F., and Penzotti, Jr. S. C. 1995. Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene like enhancers: in vivo-in vitro correlations. J. Control. Rel. 34:43-51.
10. Katayama, K., Takahashi, O., Matsui, R., Morigaki, S., Aiba, T., Kakemi, M., and Koizumi, T. 1992. Effect of 1-menthol on the permeation of indomethacin, mannitol and cortisone through excised hairless mouse skin. Chem. Pharm. Bull. 40:3097-3099.
11. Kemken, J., Ziegler, A., and Muller, B. W. 1991. Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: comparison of microemulsion and matrix patches as vehicle. Meth. Find. Exp. Clin. Pharmacol. 13:361-365.
12. Kemken, J., Ziegler, A., and Muller, B. W. 1992. Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm. Res. 9:554-558.
13. Kunta, J. R., Goskonda, V. R., Brotherton, H. O., Khan, M. A., and Reddy, I. K. 1997. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 86:1369-1373.
14. LeBrun, P. P. H., Fox, P. L. A., de Vries, M. E., and Bodde, H. E. 1989. In vitro penetration of some beta adrenoreceptor blocking drugs through porcine buccal mucosa. Int. J. Pharm. 49:141-145.
15. Morimoto, Y., Sugibayashi, K., Koboyashi, D., Shoji, H., Yamazaki, J. I., and Kimura, M. 1993. A new enhancer-coenhancer system to increase skin permeation of morphine hydrochloride in vitro. Int. J. Pharm. 91:9-14.
16. Morimoto, Y., Wada, Y., Seki, T., and K. Sugibayashi, K. 2002. In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and 1-menthol. Biol. Pharm. Bull. 25:134-136.
17. Ogiso, T., and Shintani, M. 1990. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J. Pharm. Sci. 79:1065-1071.
18. Ogiso, T., Hata, T., Iwaki, M., and Tanino. T. 2001. Transdermal absorption of bupranolol in rabbit skin in vitro and in vivo. Biol. Pharm. Bull. 24:588-591.
19. Okabe, H., Obata, Y., Takayama, K., and Nagai, T. 1990. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Design Deliv. 6:229-238.
20. Osborne, D. W., and Henke, J. J. 1997. Skin penetration enhancers cited in the technical literature. Pharm. Technol. 22:58-66.
21. Touitou, E., and Abed, L. 1985. Effect of propylene glycol, azone and n-decylmethyl sulfoxide on skin permeation kinetics of 5-fluorouracil. Int. J. Pharm. 27:89-98.
22. Valenta, C., and Wedding, C. 1997. Effects of penetration enhancers on the in vitro percutaneous absorption of progesterone. J. Pharm. Pharmacol. 49:955-959.
23. Waller, A. R., Chasseaud, L. F., Bonn, R., Taylor, T., Darragh, A. R., Girkin, R., Down, W. H., and Doyle, E. 1982. Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys. Drug Metab. Dispos. 10:51-54.
24. Weiss, I., Wolff, M., Cordes, G., and Cawello, W. 1987. Transdermal delivery of bupranolol. In Transdermal Controlled Systemic Medications, ed. Y. W. Chien, 333-345. New York: Marcel Dekker.
25. Wellstein, A., Kuppers, H., Pitschner, H. F., and Palm. D. 1986. Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy. Eur. J. Clin. Pharmacol. 31:419-422.
26. Williams, A. C., and Barry, B. W. 2004. Penetration enhancers. Adv. Drug Deliv. Rev. 56:603-618.
27. Yoneto, K., Ghanem, A. H., Higuchi, W. I., Peck, K. D., and Li, S. K. 1995. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J. Pharm. Sci. 84:312-317.
28. Zhao, K., and Singh, J. 1999. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J. Control. Rel. 62:359-366.